Have a question?
Please get in touch with our team in case of any queries
THE GLOBAL IVD CONTRACT MANUFACTURING MARKET SIZE IS EXPECTED TO REACH USD 28.89 BILLION BY 2029 FROM USD 17.13 BILLION IN 2023, GROWING AT A CAGR OF 9.11% DURING THE FORECAST PERIOD.
The IVD Contract Manufacturing Market Size, Share, & Trends Analysis Report By
- Product Type: IVD Reagents & Consumables and IVD Instrumentation & Software
- Service Type: IVD Manufacturing, Assay Development, and Others
- Technology: Immunoassay & Clinical Chemistry, Molecular Diagnostics, Microbiology & Cytology, Hematology, and Others
- Geography: North America, Europe, APAC, Latin America, and Middle East & Africa
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast 2024–2029.
This report includes market data points, ranging from trend
analyses to market estimates & forecasts that you can customize
IVD CONTRACT MANUFACTURING MARKET REPORT SCOPE
REPORT ATTRIBUTE | DETAILS |
---|---|
Market Size (2029) | USD 28.89 Billion |
Market Size (2023) | USD 17.13 Billion |
CAGR (2023-2029) | 9.11% |
HISTORIC YEAR | 2020-2022 |
BASE YEAR | 2023 |
FORECAST YEAR | 2024-2029 |
SEGMENTS BY | Product Type, Service Type, Technology, Geography |
GEOGRAPHIC ANALYSIS | North America, Europe, APAC, Latin America, and Middle East & Africa |
KEY PLAYERS | Bio-Techne, Celestica, Jabil, Merck KGaA, Savyon Diagnostics, STRATEC SE, and Thermo Fisher Scientific |
MARKET OVERVIEW
The global IVD contract manufacturing market size was valued at USD 17.13 billion in 2023 and is expected to reach USD 28.89 billion by 2029, growing at a CAGR of 9.11% during the forecast period. The global market is integral to the healthcare industry, encompassing outsourcing manufacturing processes for diagnostic tests and devices. This market is driven by increasing demand for accurate and efficient diagnostic solutions across various medical disciplines, including immunoassays, molecular diagnostics, clinical chemistry, microbiology, and hematology. Key factors propelling IVD contract manufacturing market growth include the rising prevalence of chronic and infectious diseases, technological advancements in diagnostic technologies, and the need for cost-effective production solutions.
Manufacturers in the IVD contract manufacturing sector focus heavily on R&D to innovate new diagnostic products, enhance assay sensitivity and specificity, and integrate digital health technologies for improved data management and patient care. North America and Europe hold a significant share of the global IVD contract manufacturing market, supported by robust healthcare infrastructure, stringent regulatory frameworks, and high healthcare expenditures. However, the Asia-Pacific region is experiencing rapid growth due to increasing healthcare investments, expanding patient populations, and rising adoption of advanced diagnostic technologies. Furthermore, the IVD contract manufacturing market is poised for continued expansion, driven by advancements in personalized medicine, genomic testing, and the shift toward value-based healthcare models. Strategic partnerships, mergers, and acquisitions are expected to shape the competitive landscape, fostering innovation and market differentiation among manufacturers. Overall, the market's evolution promises to enhance diagnostic capabilities, improve patient outcomes, and address global healthcare challenges in the years to come.
MARKET TRENDS & DRIVERS
Automation in Clinical Laboratory Techniques
Automation
in clinical laboratory techniques involves using advanced robotics and software
systems to streamline and enhance diagnostic processes. This includes automated
sample handling, analysis, and result reporting, which improves accuracy,
reduces turnaround times, and increases laboratory efficiency. For IVD contract
manufacturers, automation presents opportunities to develop and supply
integrated systems and components that support high throughput testing
environments, ensuring reliable and cost-effective diagnostic solutions.
Expanding Private Labelling Application
The
expanding application of private labeling is a key driver of the IVD contract
manufacturing market. This offers numerous benefits, including cost efficiency,
customization, rapid market entry, and scalability, making it an attractive
option for companies seeking to compete in the dynamic IVD industry. As private
labeling continues to gain momentum, it is fostering innovation, enhancing
product accessibility, and shaping the future of diagnostic healthcare. The collaboration
between private label brands and contract manufacturers is poised to unlock new
opportunities and drive growth in the global IVD market, ultimately improving
healthcare outcomes worldwide.
Booming Molecular Diagnostic Sector & Growing R&D Focus on Assay
Development
The
molecular diagnostic sector has grown significantly due to technological
advancements such as PCR, DNA sequencing, and microarrays. There is a strong
emphasis on developing molecular assays for detecting genetic disorders,
infectious diseases, and oncology biomarkers with high sensitivity and
specificity. IVD contract manufacturers can capitalize on this trend by
collaborating with diagnostic companies to design and manufacture molecular
assay kits, reagents, and instruments. This requires expertise in scalable
production, regulatory compliance, and continuous innovation to meet evolving
market demands.
Growing Outsourcing by IVD OEMs
The
growing outsourcing by IVD OEMs is a significant driver of the global IVD
contract manufacturing market. Pursuing cost efficiency, access to advanced
technologies, regulatory compliance, and the ability to focus on core
competencies are key factors influencing this trend. As the IVD industry
continues to evolve, the symbiotic relationship between OEMs and CMOs will play
a crucial role in delivering high-quality diagnostic products to meet the needs
of patients and healthcare providers worldwide. This dynamic partnership is set
to shape the future of the IVD market, fostering innovation and growth in the
years to come.
Complexities in Product Design & Constant Technological Advancements
The
complexities inherent in in-house product design and the continuous
technological advancements in the IVD industry are propelling the growth of the
global IVD contract manufacturing market. By partnering with specialized
contract manufacturers, IVD companies can more effectively navigate product
development challenges, regulatory compliance, and market demand. This
collaborative approach accelerates innovation and ensures that cutting-edge
diagnostic tools are available to meet the evolving needs of healthcare
providers and patients worldwide. As the IVD market continues to expand, the
role of contract manufacturers will become increasingly vital in driving its
growth and success.
Growing Strategic Collaborations OEM & Contract Manufacturers
The
growing strategic collaborations between OEMs and contract manufacturers drive
the global IVD contract manufacturing market, offering numerous benefits such
as accelerated time-to-market, technological advancements, cost efficiency,
regulatory compliance, and market expansion. As the IVD industry evolves, these
partnerships will remain crucial in meeting the increasing demand for
high-quality diagnostic solutions, ultimately improving healthcare outcomes
worldwide.
SEGMENTATION INSIGHTS
INSIGHTS BY PRODUCT TYPE
The
global IVD contract manufacturing market by product type is segmented into IVD
reagents & consumables and IVD instrumentation & software. IVD reagents
and consumables constitute a dominant portion of the contract manufacturing
market, encompassing a wide range of products essential for diagnostic testing.
The increasing prevalence of chronic and infectious diseases, advancements in
diagnostic technologies, and the shift towards personalized medicine drive
demand for specialized reagents and consumables. The market for IVD reagents
and consumables is expanding globally, supported by the growing volume of
diagnostic tests performed in clinical laboratories, hospitals, and
point-of-care settings. Furthermore, IVD instrumentation and software encompass
sophisticated analytical instruments and digital solutions used in diagnostic
laboratories and healthcare facilities. Automated systems, analyzers,
platforms, and devices used for conducting diagnostic tests, such as
immunoassay analyzers, clinical chemistry analyzers, hematology analyzers, PCR
instruments, and next-generation sequencing (NGS) platforms. Also, integrated
software solutions that manage data acquisition, analysis, interpretation, and
reporting of diagnostic results.
Rapid diagnostic instrumentation and software innovation focuses on enhancing diagnostic accuracy, throughput, and operational efficiency. Key advancements include miniaturization, automation, and integration with digital health technologies. Healthcare facilities and diagnostic laboratories increasingly adopt advanced instrumentation and software to meet the growing demand for faster, more precise diagnostic testing and to comply with regulatory requirements. Manufacturers offer customizable instrumentation and software solutions tailored to specific diagnostic needs and laboratory workflows, enabling seamless integration with existing systems and enhancing user experience.
INSIGHTS BY SERVICE TYPE
The
global IVD contract manufacturing market by service type is segmented into IVD manufacturing,
assay development, and others. IVD manufacturing held the largest segmental
market share. IVD manufacturing involves producing and assembling diagnostic
devices, instruments, reagents, and consumables used in clinical laboratories,
hospitals, and other healthcare settings. Contract manufacturers specialize in
manufacturing various components and systems required for in vitro diagnostic tests.
This includes immunoassays, molecular diagnostics, clinical chemistry
analyzers, hematology analyzers, and microbiology testing kits. Services
typically include procurement of raw materials, production planning, quality
control testing, packaging, and logistics management. Manufacturers ensure
adherence to stringent regulatory standards (e.g., FDA, CE marking) and
maintain high-quality assurance throughout the manufacturing process.
Furthermore, assay development services involve designing, optimizing, and
validating diagnostic assays and test protocols used to detect specific
biomarkers, pathogens, or genetic variations. Contract manufacturers
collaborate with diagnostic companies to develop custom assays to meet specific
clinical requirements and performance criteria. This may include developing
multiplex assays, point-of-care testing (POCT) devices, and companion
diagnostics.
Beyond manufacturing and assay development, contract manufacturers offer a range of ancillary services to support diagnostic product development and commercialization. This includes regulatory consulting, technical support, training programs, and supply chain management services. Regulatory consulting ensures compliance with global regulations and assists in obtaining necessary approvals and certifications.
INSIGHTS BY TECHNOLOGY
The
global IVD contract manufacturing market by technology is segmented into
immunoassay & clinical chemistry, molecular diagnostics, microbiology &
cytology, hematology, and others. The immunoassay & clinical chemistry
segment held the most prominent global market share in 2023. Immunoassay and
clinical chemistry stand out among the various technologies employed in this
field due to their wide range of applications and reliability. These
technologies are central to the IVD contract manufacturing market, providing
essential tools for developing and producing diagnostic tests that meet the
stringent requirements of healthcare providers and regulatory bodies. Also, the
segment growth is driven by the increasing prevalence of chronic diseases and
the need for rapid and accurate diagnostic results. Furthermore, rapid genomics
and personalized medicine advancements drive the demand for molecular
diagnostics. The market is characterized by continuous innovation in
technologies like next-generation sequencing (NGS) and digital PCR, enabling
precise disease diagnosis and treatment monitoring.
GEOGRAPHICAL ANALYSIS
North America held the largest share of the global IVD contract manufacturing market, accounting for a global share of over 35% in 2023. The North American in vitro diagnostics (IVD) contract manufacturing market is a vital component of the healthcare industry, enabling the development and delivery of advanced diagnostic solutions. With a strong focus on regulatory compliance, technological innovation, and specialized expertise, CMOs in North America are well-positioned to meet the evolving needs of the diagnostic market. As the demand for accurate, reliable, and accessible diagnostic tools grows, the regional market is poised for continued expansion and success. Furthermore, the European IVD contract manufacturing market is poised for continued growth, driven by rising healthcare demands, technological advancements, and stringent regulatory standards. As diagnostic companies seek efficient and compliant manufacturing solutions, contract manufacturers are pivotal in enabling innovation, scalability, and market competitiveness. By leveraging their expertise in specialized manufacturing processes and embracing emerging trends, European IVD contract manufacturers are well-positioned to meet the evolving needs of the diagnostic industry and contribute to improved healthcare outcomes across the region.
The APAC IVD contract manufacturing market represents a dynamic and expanding sector within the global healthcare industry. As diagnostic companies prioritize innovation and market expansion, partnerships with specialized contract manufacturers in the APAC region will be crucial in meeting healthcare demands, driving technological advancement, and improving patient outcomes across diverse healthcare settings. By leveraging regional strengths, embracing technological innovation, and navigating regulatory landscapes effectively, IVD contract manufacturers can capitalize on growth opportunities and contribute to advancing healthcare accessibility and quality in the APAC region and beyond. Furthermore, Latin America's IVD contract manufacturing market is poised for significant growth, driven by increasing healthcare demands, technological advancements, and a focus on early disease detection. Also, the Middle East & Africa IVD contract manufacturing market is poised for growth, driven by increasing healthcare demands, regulatory reforms, and technological advancements. As diagnostic companies seek to capitalize on these opportunities, partnerships with specialized contract manufacturers will play a crucial role in expanding market presence and delivering innovative diagnostic solutions to healthcare providers and patients across the Middle East and Africa.
VENDOR LANDSCAPE
The global IVD contract manufacturing market is characterized by intense competition among players, including multinational corporations, regional manufacturers, and specialized CMOs. Large multinational companies dominate significant market shares due to their extensive R&D capabilities, global presence, and diversified product portfolios. These companies often have established relationships with leading diagnostic firms and healthcare providers, enabling them to offer comprehensive contract manufacturing services across multiple diagnostic disciplines. Some of the key players in the global IVD contract manufacturing market include Bio-Techne, Celestica, Jabil, Merck KGaA, Savyon Diagnostics, STRATEC SE, and Thermo Fisher Scientific. Furthermore, technological innovation is a key driver of competition in the IVD contract manufacturing market. Companies invest heavily in R&D to develop advanced diagnostic platforms, improve assay performance, and enhance automation capabilities. Technologies such as next-generation sequencing, digital PCR, and microfluidics are transforming diagnostic workflows, offering faster turnaround times, increased sensitivity, and reduced costs.
Bio-Techne, a prominent player in the biotechnology sector, has made significant contributions to the global IVD contract manufacturing market. Bio-Techne offers an extensive range of reagents, assay kits, and diagnostic tools integral to developing and manufacturing IVD products. Their expertise spans various diagnostic disciplines, including immunoassays, molecular diagnostics, and clinical chemistry. The company invests significantly in research and development to stay at the forefront of technological advancements in the IVD field. Bio-Techne’s innovations include cutting-edge molecular diagnostic techniques, advanced immunoassay platforms, and novel biomarkers. Further, their state-of-the-art manufacturing facilities and adherence to stringent quality control standards ensure that the products meet regulatory requirements and industry benchmarks. The company’s robust quality assurance processes and certification to ISO standards reinforce its commitment to delivering safe and effective diagnostic products.
Frequently Asked Questions
How big is the IVD contract manufacturing market?
What is the growth rate of the global IVD contract manufacturing market?
What are the significant trends in the IVD contract manufacturing market?
Which region dominates the global IVD contract manufacturing market share?
The global IVD contract manufacturing market size is expected to grow at a CAGR of approximately 9.11% from 2023 to 2029.
The following factors are likely to contribute to the growth of the global IVD contract manufacturing market during the forecast period:
- Growing Outsourcing by IVD OEMs
- Rising Patient Demographics Shift with High Demand for IVD Tests & Devices
- Complexities in Product Design & Constant Technological Advancements
- Expanding Private Labelling Application
- Growing Strategic Collaborations OEM & Contract Manufacturers
Base Year: 2023
Forecast Year: 2024-2029
The report considers the present scenario of the global IVD contract manufacturing market and its market dynamics for 2024−2029. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the industry. It also profiles and analyzes leading companies and several other prominent companies operating in the industry.
- Bio-Techne
- Business Overview
- Product Offerings
- Key Strategies
- Key Strengths
- Key Opportunities
- Celestica
- Jabil
- Merck KGaA
- Savyon Diagnostics
- STRATEC SE
- Thermo Fisher Scientific
- Other Prominent Vendors
- Aalto Scientific
- Business Overview
- Product Offerings
- Abingdon Health
- ACON Laboratories
- Advy Chemical
- Affinity Life Sciences
- Argonaut Manufacturing Services
- Avioq
- BIT Analytical Instruments GmbH
- Calbiotech
- Coris BioConcept
- DCN Diagnostics
- ECLEVAR
- EKF Diagnostics
- ERREKA Medical
- Fapon Biotech
- Fujirebio
- Hardy Diagnostics
- Hochuen Medical
- In Vitro Diagnostic Solutions
- InBios International
- Invetech
- IVD Research
- Jena Bioscience GmbH
- PHC Corporation
- Prestige Diagnostics
- SCIENION
- TCS Biosciences
- TE Connectivity
- Veracyte
- Zentech
- Segmentation by Product Type
- IVD Reagents & Consumables
- IVD Instrumentation & Software
- Segmentation by Service Type
- IVD Manufacturing
- Assay Development
- Others
- Segmentation by Technology
- Immunoassay & Clinical Chemistry
- Molecular Diagnostics
- Microbiology & Cytology
- Hematology
- Others
- Segmentation by Geography
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- The U.K.
- Russia
- Netherlands
- APAC
- China
- India
- Japan
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East & Africa
- Turkey
- South Africa
- Saudi Arabia
- UAE
For more details, please reach us at [email protected]
For more details, please reach us at [email protected]
Select a license type that suits your business needs
Single User Licence
- Report accessible by one user only
- Free 10% or 3 days of customization
- Free post-sale service assistance
- Continuous support through email
5 User Licence
- Report accessible by 5 users within the organization
- Free 15% or 4.5 days of customization
- Continuous support through email and telephone
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Corporate Licence
- Free Datasheet worth $1500
- Report accessible by the entire organization
- Free 20% or 6 days of customization
- Free post-sale service assistance
- Continuous support through email and telephone
- Direct access to lead analysts
- Free analyst hour
- Free Upgrade: If an updated report published within 180 days of purchase, you will get the revised report free of charge
Datasheet Licence
- Report accessible by 1 user only
- Free 15% or 32 hours of customization
- Free post-sale service assistance
- Direct access to lead analysts
Frequently Asked Questions
How big is the IVD contract manufacturing market?
What is the growth rate of the global IVD contract manufacturing market?
What are the significant trends in the IVD contract manufacturing market?
Which region dominates the global IVD contract manufacturing market share?